TheRightDoctors Logo
Pre Alpha
Insights from the World's Best Medical Minds
nine

Pause
Love It
Download

Dr. Pushpendra Rajan

Stroke Neurologist,

Apollo Hospital


The introduction of the NOACs in the last few years has again revised the treatment of AF. There are various agents and main stream of treatment being dabigatran, Pradaxa which is available for us for the treatment of patients with atrial fibrillation.

Mail us at editorial@therightdoctors.com. Stay updated on Facebook , Twitter , You Tube and LinkedIn.
<br> Dr.Pushpendran Ranjan

</b> Last decade has seen significant advances in the management of acute ischemic stroke. The people with acute ischemic stroke have begun to visualize by seeking the patients from as early as 3-4.5 hours with acute thrombolytic therapy. As acute thrombolytic therapy has become the main stream of treatment for the treatment of acute ischemic stroke. Going further for the second deprivation of stroke for the atrial fibrillation which accounts for the major cause of stroke after the age of 65 to 70 years, (1



  • Heart attack
  • STEMI
  • Primary PCI
  • Angioplasty
  • Heart Failure
  • ECHO

Join TheRightDoctors on WhatsApp. Type "JOIN" and send to 9676401536